Plasmacytomagenesis in mice: Model of neoplastic development dependent upon chromosomal translocations

Carcinogenesis

Volumn 13, Issue 10, 1992, Pages 1681-1697

  Potter, Michael ^a,b   Wiener, Francis ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN J CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 6; LIQUID PARAFFIN; LYMPHOCYTE ANTIGEN; PLASTIC; PRISTANE;

ABELSON MURINE LEUKEMIA ONCOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 12; CHROMOSOME 15; CHROMOSOME 16; CHROMOSOME 6; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; GENE REARRANGEMENT; GENETIC SUSCEPTIBILITY; H2 SYSTEM; HISTOGENESIS; IMMUNE STATUS; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; INBRED STRAIN; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; PERITONEUM; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; VIRUS CARCINOGENESIS; VIRUS ONCOGENE;

ANIMAL; CHROMOSOMES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED DBA; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PLASMACYTOMA; TRANSLOCATION (GENETICS);

EID: 0026767880     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/13.10.1681     Document Type: Review

References (157)

1. Potter, M. (1972) Immunoglobulin-producing tumors and myeloma proteins in mice. Physiol. Rev., 52, 631-719.
2. Potter, M. (1977) Antigen-binding myeloma proteins of mice. In Advances in Immunology. Academic Press, New York, Vol. 25, pp. 141-211.
3. Dunn, T.B. (1957) Plasma cell neoplasms beginning in the ileocecal area in strain C3H mice. J. Natl. Cancer Inst., 19, 371-391.
4. Rask-Nielsen, R. and Gormsen, H. (1956) On the occurrence of plasma-cell leukemia in various strains of mice. J. NatL Cancer Inst., 16, 1137-1147.
5. Rask-Nielsen, R., Gormsen, H. and Clausen J. (1959) A transplantable plasma-cell leukemia in mice associated with the production of beta-paraprotein. J. Natl. Cancer Inst., 22, 509-541.
6. Radl, J., Croese, J.W., Zurcher, C., Enden-Vieveen, MHM. and de Leeuw, A.M. (1988) Animal model of human disease. Multiple myeloma. Am. J. Pathol., 132, 593-597.
7. Merwin, R.M. and Algire, G.H. (1959) Induction of plasma cell neoplasms and fibrosarcomas in BALB/c mice carrying diffusion chambers. Proc. Soc. Exp. Biol. Med., 101, 437-439.
8. Merwin, R.M. and Redmon, L.W. (1963) Induction of plasma cell tumors and sarcomas in mice by diffusion chambers placed in the peritoneal cavity. J. Natl. Cancer Inst., 31, 990-1007.
9. Dux, K., Rouse, R.V. and Kyewski, B. (1986) Composition of the lymphoid cell populations from omental milky spots during the immune response in C57BL/Ka mice. Eur. J. Immunol., 16, 1029-1032.
10. Dux, K., Janik, P. and Szaniawska, B. (1977) Kinetics of proliferation, cell differentiation, and IgM secretion in the omental lymphoid organ of BlO/Sn mice following intraperitoneal immunization with sheep erythrocytes. Cell. Immunol., 32, 97-109.
11. Cranshaw, M.L. and Leak, L.V. (1990) Milky spots of the omentum: a source of peritoneal cells in the normal and stimulated animal. Arch. Histol. Cytol., 53, 165-177.
12. Solvason, N., Leheun, A. and Kearney, J.F. (1991) An embryonic source of Lyl but not conventional B cells. Int. Immunol., 3, 543-550.
13. Brand, K.G. (1987) Solid state carcinogenesis. Banbury Report 25: Nongenotoxic Mechanisms in Carcinogenesis. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 205-213.
14. Oppenheimer, B.S., Oppenheimer, E.T., Danishetsky, I., Stout, A.P. and Elrich, F.R. (1955) Further studies of polymers as carcinogenic agents in animals. 15, 333-340.
15. Lieberman, R., Douglas, J.O.A. and Mantel, N. (1960) Production in mice of ascitic fluid containing antibodies induced by staphylococcus-or salmonella-adjuvant mixtures. J. Immunol., 84, 514-529.
16. Potter, M. and Robertson, C.L. (1960) Development of plasma-cell neoplasms in BALB/c mice after intraperitoneal injection of paraffm-od adjuvant, heat-killed staphylococcus mixtures. J. Natl. Cancer Inst., 25, 847-861.
17. Potter, M. and Boyce, C. (1962) Induction of plasma cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants. Nature, 193, 1086.
18. Potter, M. (1982) Pathogenesis of plasmacytomas in mice. In Becker, F.F. (ed.), Cancer: a Comprehensive Treatise. Plenum Press, New York, p. 139.
19. Anderson, P.N. and Potter, M. (1969) Induction of plasma cell tumours in BALB/c mice with 2, 6, 10, 14-tetramethylpentadecane (pristane). Nature, 222, 994-995.
20. Anderson, P.N. (1970) Plasma cell tumor induction in BALB/c mice. Proc. Am. Assoc. Cancer Res., 11, 3 (abstract).
21. Potter, M. and Wax, J.S. (1983) Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens. J. Natl. Cancer Inst., 71, 391-395.
22. Potter, M. and MacCardle, R.C. (1964) Histology of developing plasma cell neoplasia induced by mineral oil in BALB/c mice. J. Natl. Cancer Inst., 33, 497.
23. Leak, L.V., Potter, M. and Mayfield, W.J. (1985) Response of the peritoneal mesothelium to the mineral oil, pristane. Curr. Top. Microbiol. Immunol., 122, 221-233.
24. Anderson, A. O., Wax, J.S. and Potter, M. (1985) Differences in the peritoneal response to pristane in BALB/cAnPt and BALB/cJ mice. Curr. Top. Microbiol Immunol., 122, 242-253.
25. Shacter, E., Beecham, E.J., Covey J.M., Kohn, K.W. and Potter, M. (1988)Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis, 9, 2297-2304.
26. Takakura, K., Yamada, H. and Hollander, V.P. (1966) Studies on the pathogenesis of plasma cell tumors. II. The role of mast cells and pituitary glycoprotein hormones in the inhibition of plasma cell tumorigenesis. Cancer Res., 26, 2564-2569.
27. Cancro, M. and Potter, M. (1976) The requirement of an adherent cell substratum for the growth of developing plasmacytoma cells in vivo. J. Exp. Med., 144, 1554-1567.
28. Potter, M., Wax, J.S., Anderson, A.O. and Nordan, R.P. (1985) Inhibition of plasmacytoma development in BALB/c mice by indomethacin. J. Exp. Med., 161, 996-1012.
29. Shacter, E., Arzadon, G.K., and Williams, J. (1992) Elevation of IL-6 response to a chronic inflammatory stimulus in mice: inhibition by indomethacin. Blood, in press.
30. Shacter, E., Lopez, R.L. and Pati, S. (1991) Inhibition of the myeloperoxidase-H202-Cr system of neutrophils by indomethacin and other non-steroidal anti-inflammatory drugs. Biochem. Pharmacol., 41, 975-984.
31. Morse, H.C., III, Hartley J.W. and Potter, M. (1980) Genetic considerations in plasmacytomas of BALB/c NZB and (BALB/c x NZB)F1 mice. In Potter, M. (ed.), Progress in Myeloma. Biology of Myeloma. Elsevier/North Holland, New York, p. 263.
32. Warner, N.L. (1975) Autoimmunity and the pathogenesis of plasma cell tumor induction in NZB and hybrid mice. Immunogenetics, 2, 1.
33. Potter, M., Wax, J.S. and Blankrnhom, E. (1985) BALB/c subline differences in susceptibility to plasmacytoma induction. Curr. Top. Microbiol Immunol., 122, 234-241.
34. Potter, M., Wax, J.S. and Blankenhom, E. (1985) BALB/c subline differences in susceptibility to plasmacytoma induction. Curr. Top. Microbiol Immunol., 122, 234-241.
35. Potter, M. and Wax, J.S. (1981) Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J. Immunol., 127, 1591-1595.
36. Murphy, W.H. and Bdgos, G.L. (1985) Characteristics of the wm substrain of BALB/c mice. Curr. Top. Microbiol. Immunol., 122, 38-42.
37. Morse, H.C., III, Riblet, R., Asofsky, R. and Weigert, M. (1978)Plasmacytomas of the NZB mouse. J. Immunol., 121, 1969-1972.
38. Holmes, M.C. and Burnet, F.M. (1963) The natural history of autoimmune disease in NZB mice. Ann. Int. Med., 59, 265-276.
39. Harris, LJ., Lang, R.B. and Marcu, K.B. (1982) Non-immunoglobulin-associated DNA rearrangements in mouse plasmacytomas. Proc. NatL Acad. Sci. USA, 79, 4175-4179.
40. Harris, LJ., Remmers, E.F., Brodeur, P., Riblet, R., D’Eustachio, P. and Marcu, K.B. (1983) c-myc gene rearrangements involving gamma immunoglobulin heavy chain gene switch regions in murine plasmacytomas. Nucleic Acids Res., 11, 8303-8315.
41. Raveche, E.S., Tjio, J.H. and Steinberg, A.D. (1979) Genetic studies in NZB mice. Cytogenet. Cell Genet., 23, 182-193.
42. Emerit, J., Feingold, J., Levy, A., Martin, E. and Housset, E. (1980) Tumor incidence and development of autoimmune hemolytic anemia in two breeding lines of the NZB mouse strain that differ in chromosome breakage. J. Natl. Cancer Inst., 64, 513-517.
43. Fialkow, PJ., Palon, G.R. and East, J. (1973) Chromosomal abnormalities in spleens of New Zealand black mice, a strain characterized by autoimmunity and malignancy. Proc. Natl. Acad. Sci. USA, 70, 1094-1098.
44. Fialkow, PJ., Bryant, J.I. and Friedman J.M. (1978) Specificity of acquired clonal chromosome abnormalities in New Zealand black mice. Int. J. Cancer, 21, 505-510.
45. Reddy, A.L., Fialkow, PJ. and Salo, A. (1978) Ultraviolet radiation-induced chromosomal abnormalities in fetal fibroblasts from New Zealand black mice. Science, 201, 920-922.
46. Potter, M., Sanford, K.K., Parshad, R., Tarone, R.E., Price, F.M., Mock, B. and Huppi, K. (1988) Genes on chromosomes 1 and 4 in the mouse arc associated with repair of radiation-induced chromatin damage. Genomics, 2, 257-262.
47. Potter, M., Hartley, J.W., Wax, J.S. and Gallahan, D. (1984) Effect of MuLV related genes on plasmacytomagenesis in BALB/c mice. J. Exp. Med., 160, 435-440.
48. Silva, S., Sugiyama, H., Babonits, M., Wiener, F. and Klein, G. (1990)Plasmacytoma induction in BALB/c6;15 -DBA/2 chimeras. In Potter, M. and Melchers, F. (eds), Current Topics in Microbiology and Immunology. Vol. 166: Mechanisms in B-Cell Neoplasia. Springer-Verlag, Heidelberg, pp. 97-105.
49. Silva, S., Babonits, M., Wiener, F. and Klein, G. (1989) Plasmacytoma induction in radiochimeras. Int. J. Cancer, 44, 337-342.
50. Sanford, C. K., Parshad, R., Gantt, R.R. and Tarone, I, E. (1989) A deficiency in chromatin repair, genetic instability, and predisposition to cancer. CRC. Crit. Rev. Oncogenesis, 1, 323-341.
51. Bohr, V.A. (1991) Gene specific DNA repair. Carcinogenesis, 12, 1983-1992.
52. Beecham, EJ., Mushinski, J.F., Shacter, E., Potter, M. and Bohr, V.A. (1991)DNA repair in the c-myc proto-oncogene locus: possible involvement in susceptibility or resistance to plasmacytoma induction in BALB/c mice. Mol. Cell. Biol., 11, 3095-3104.
53. Beecham, EJ., Mushinski, J.F., Shacter, E., Potter, M. and Bohr, V.A. (1990)DNA repair in the c-myc locus. In Potter, M. and Melchers, F. (eds). Current Topics in Microbiology and Immunology, Vol. 166: Mechanisms in B-Cell Neoplasia, Springer-Veriag, Heidelberg, pp. 285-291.
54. Johnson, R.T., Collins, A.R.S., Squires, S., Mullinger, A.M., Elliott, G.C., Downes, C.S. and Rasko, I. (1987) DNA repair under stress. J. Cell Sci., 6, 263-288.
55. McIntire, K.R. and Princler, G.L. (1969) Prolonged adjuvant stimulation in germ-free BALB/c mice development of plasma cell neoplasia. Immunology, 17, 481-487.
56. Byrd, L.G., McDonald, A.H., Gold, L.G. and Potter, M. (1991) Specific pathogen free BALB/cAn mice are refractory to plasmacytoma induction by pristane. Unpublished results.
57. Potter, M., Pumphrey, J.G. and Walters^, L. (1972) Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment. J. Nad. Cancer Inst., 49, 305-308.
58. Potter, M. (1987) Plasmacytoma development in BALB/c mice. Adv. Viral Oncol., 7, 99-122.
59. Degrassi, A., Hilbert, D.M., Anderson, A.O., Potter, M. and Coon, H.G. (1990) In vitro culture of a primary plasmacytoma that has retained its dependence on pristane conditioned microenvironment for growth. Curr. Top. Microbiol. Immunol., 166, 71-74.
60. Nordan, R.P. and Potter, M. (1986) A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science, 233, 566-569.
61. Vink, A., Vandenabeele, P., Uyttenhove, C., Cayphas, S. and Van Snick, J. (1988) Plasmacytoma growth factor activity of murine granulocyte-macrophage colony-stimulating factor. J. Immunol., 141, 1996-1999.
62. Klein, B., Zhang, X.-G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M. and Bataille, R. (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood, 73, 517-526.
63. Hardy, R.R. and Hayakawa, K. (1991) A developmental switch in B lymphopoiesis. Proc. Natl. Acad. Sci. USA, 88, 11550-11554.
64. Hayakawa, K., Hardy, R.R., Stall, A.M. and Herzenberg, L.A. (1986)Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur. J. Immunol., 16, 1313-1316.
65. Forster, I. and Rajewsky, K. (1987) Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur. J. Immunol., 17, 521-528.
66. Masmoudi, H., Mota-Santos, T., Huetz, F., Coutinho, A. and Cazenave, P.A. (1990) All T15 Id-positive antibodies (but not the majority of VHT15 + antibodies) are produced by peritoneal CD5+ B lymphocytes, bn. Immunol., 2, 515-520.
67. Lehmann, H.P. and Lehle, G. (1991) A myeloma M 104E private idiotope is represented predominantly among anti-dextran, peritoneal cavity Ly-1 + precursor B cells. Eur. J. Immunol., 21, 1201-1205.
68. Mercolino, T.J., Arnold, L.W., Hawkins, L.A. and Haughton, G. (1988)Normal mouse peritoneum contains a large population of Ly-1 + (CD5) B cells that recognize phosphatidyl choline. J. Exp. Med., 168, 687-698.
69. Kroese, F.G.M., Butcher, E.C., Stall, A.M., Lalor, P.A., Adams, S. and Herzenberg, L.A. (1988) Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Im. Immunol., 1, 75-84.
70. Potter, M. (1971) Antigen binding myeloma proteins in mice. Ann. NY Acad Sci., 190, 306-321.
71. Potter, M. (1970) Mouse IGA myeloma proteins that bind polysaccharide antigens of enterobacterial origin. Fed Proc., 29, 85-91.
72. Potter, M. and Lieberman, R. (1970) Common individual antigenic determinants in five of eight BALB/c IgA myeloma proteins that bind phosphorylcholine. J. Exp. Med., 132, 737.
73. Andrade, L., Huetz, F., Pooncet, P., Thomas-Vaslin, V., Goodhardt, M. and Coutinho, A. (1991) Biased VH gene expression in murine CD5 B cells results from age-dependent cellular selection. Eur. J. Immunol., 21, 2017-2023.
74. Potter, M., Mushinski, E.B., Rudikoff, S., Glaudemans, C.P.J., Padlan, E.A. and Davies, D.R. (1979) Structural and genetic basis of idiotypy in the galactan-binding myeloma proteins. Ann. Immunol. (Inst. Pasteur), 130, 263-271.
75. Potter, M., Sklar, M.D. and Rowe, W.P. (1973) Rapid viral induction of plasmacytomas in pristane-primed BALB/c mice. Science, 182, 592-594.
76. Sugiyama, H., Weber, G., Silva, S., Babonits, M., Wiener, F. and Klein, G. (1989) The accelerating role of Abelson murine leukemia virus in murine plasmacytoma development: in vitro infection of spleen cells generates donor-type tumors after transfer to pnstane-treated BALB/c mice. Int. J. Cancer, 44, 348-352.
77. Sugiyama, H., Silva, S., Wang, Y., Weber, G., Babonits, M., Rosen, A., Wiener, F. and Klein, G. (1990) Abelson murine leukemia virus transforms preneoplastic E-myc transgene-carrying cells of the B-lymphocytc lineage into plasmablastic tumors. Int. J. Cancer, 6, 1-8.
78. Sugiyama, H., Weber, G., Silva, S., Babonits, M., Wiener, F. and Klein, G. (1990) Induction of plasmacytomas from spleen cells infected in vitro with Abelson murine leukemia virus. Int. J. Cancer, in press.
79. Ohno, S., Migita, S., Wiener, F., Babonits, M., Klein, G., Mushinsld, J.F. and Potter, M. (1984) Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and Abelson virus. J. Exp. Med., 159, 1762-1777.
80. Shaughnessy, J., Huppi, K., Mushinski J.F. and Potter, M. (1990) Moloney murine leukemia virus integration 1060 base pairs 5' of c-myc exon 1 in a plasmacytoma without a chromosomal translocation. In Potter, M. and Melchers, F. (eds), Current Topics in Microbiology and Immunology, Vol. 166: Mechanisms in B-Cell Neoplasia. Springer-Veriag, Heidelberg, pp. 303-306.
81. Freed, E. and Hunter, T. (1991) A41-kilodalton protein is a potential substrate for the p210 bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells. Mol. Cell. Biol., 12, 1312-1323.
82. Wang, J.Y.J. (1988) Negative regulation of c-abl tyrosine kinase by its variable N-terminal amino acids. Oncogene Res., 3, 293-298.
83. McWhirter J.R. and Wanh, J.Y.J. (1991) Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol. Cell. Biol., 11, 1553-1565.
84. Varticovski, L., Daley, G.Q., Jackson, P., Baltimore, D. and Cantley, L.C. (1991) Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants. Mol. Cell. Biol., 11, 1107-1113.
85. Pierce, J.H., Di Fiore, P.P., Aaronson, S.A., Potter, M., Pumphrey, J., Scott, A. and Ihle, J.N. (1985) Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell, 41, 685-693.
86. Largaespada, D., Kaehler, D., Weissinger, E., Mischak, H., Mushinski, J.F. and Risser, R. (1990) The activity of an ABL-MYC retrovirus in fibroblast cell lines and in lymphocytes. In Potter, M. and Melchers, F. (eds), Current Topics in Microbiology and Immunology, Vol. 166: Mechanisms in B-Cell Neoplasia. Springer-Veriag, Heidelberg, pp. 91-96.
87. Weissinger, E.M., Mischak, H., Largaespada, D.A., Kaehler, D.A., Mitchell, T., Smith-Gill, S.J., Risser, R. and Mushinski, J.F. (1991) Induction of plasmacytomas secreting antigen-specific moooclonal antibodies with a retrovirus expressing v-abl and c-myc. Proc. Natl. Acad Sci. USA, 88, 8735-8739.
88. Largaespada, D.A., Kaehler, D.A., Mischak, H., Weissinger, E., Potter, M., Mushinski, J.F. and Risser, R. (1991) A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas. Submitted for publication.
89. DePinho, R., Kruger, K., Andrews, N., Lutzker, S., Baltimore, D. and Alt, F.W. (1984) Molecular basis of heavy-chain class switching and switch region deletion in an Abelson virus-transformed cell line. Mol. Cell. Biol., 4, 2905-2910.
90. Corcoran, L.M., Cory, S. and Adams, J.M. (1985) Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma. Cell, 40, 71-79.
91. Adams, J.M., Harris, A. W., Pinkert, C.A., Corcoran, L.M., Alexander, W.S., Cory, S., Palmiter, R.D. and Brinster, R.L (1985) The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature, 318, 533-538.
92. Langdon, W.Y., Harris, A.W., Cory, S. and Adams, J.M. (1986) The c-myc oncogene perturbs B lymphocyte development in Eg.-myc transgenic mice. Cell, 47, 11-18.
93. Harris, A. (1991) Plasmacytomas-session 5. In Melchers, F. and Potter, M. (eds), Mechanisms of B Cell Neoplasia 1991. Editiones Roche, Basel, pp. 367-372.
94. Rosenbaum, H., Harris, A.W., Bath, M.L., McNeall, J., Webb, E., Adams, J.M. and Cory, S. (1990) An Ep-v-abl transgene elicits plasmacytomas in concert with an activated myc gene. EMBO J., 9, 897-905.
95. Suematsu, S., Matsuda, T., Aozasa, K., Alrira, S., Nakano, N., Ohno, S., Miyazaki, J.-I., Yamamura, C.-I., Hirano, T. and Kisfumoto, JL (1989) IgGl plasmacytosis in interleukin 6 transgenic mice. Proc. NatL Acad Sci. USA, 86, 7547-7551.
96. Hirano, T. (1991) Plasmacytomas. In Melchers, F. and Potter, M. (eds), Mechanisms of B Cell Neoplasia. Editiones Roche, Basel, pp. 375-379.
97. Strasser, A., Whittingham, S., Vaux, D.L, Bath, M.L., Adams, J.M., Cory, S. and Harris, A.W. (1991) Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA, 88, 8661-8665.
98. McDonnell, T.J. and Korsmeyer, SJ. (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the T(14; 18). Nature, 349, 254-256.
99. Hockenberry, D.M., Zutter, M., Hickey, W., Nahm, M. and Korsmeyer, SJ. (1991) BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA, 88, 6961-6965.
100. Lenoir, G.M., and Taub, R. (1987) Chromosomal translocations and oncogenes in Burldtt’s lymphoma. In Golman, J.M. and Hamden, D.H. (eds), Genetic Rearrangements in Leukaemia and Lymphoma. Churchill-Livingstone, New York, pp. 152-172.
101. Pear, W.S., Ingvarsson, S., Steffen, D., Mflnke, M., Francke, U., Bazin, H., Klein, G. and Sumegi, J. (1986) Multiple chromosomal rearrangements in a spontaneously arising T(6;7) rat immunocytoma juxtapose c-myc and immunoglobulin heavy chain sequences. Proc. Natl. Acad. Sci. USA, 83, 7376-7380.
102. Pear, W.S., WahlstrcSm, G., Nelson, S.F., Axelson, H., Szeles, A., Wiener, F., Bazin, H., Klein, G. and Sumegi, J. (1988) 6;7 chromosomal translocation in spontaneously arising rat immunocytomas: evidence for c-myc breakpoint clustering and correlation between isotypic expression and the c-myc target. Mol. Cell. Biol., 8, 441-451.
103. Pelicci, P.G., Knowles, D.M., Magrath, I. and Dalla-Favera, R. (1986)Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc. Natl. Acad. Sci. USA, 83, 2984-2988.
104. Cory, S. (1986) Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv. Cancer Res., 47, 189-211.
105. Marcu, K. (1992) Review. Anna. Rev. Immunol., in press.
106. Winter, E., Krawinkel, U. and Radbruch, A. (1987) Directed Ig class switch recombination in activated murine B cells. EMBO J., 6, 1663-1671.
107. Geroodakis, S., Cory, S. and Adams, J.M. (1984) Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange. Cell, 36, 973-982.
108. Dunnick, W., Shell, B.E. and Dery, C. (1983) DNA sequences near the site of reciprocal recombination between a c-myc oncogene and an v. immunoglobulin switch region. Proc. Natl. Acad Sci. USA, 80, 7269-7273.
109. Williams, M. and Maizels, N. (1991) LR1, a lipopolysaccharide-responsive factor with binding sites in the immunoglobulin switch regions and heavy-chain enhancer. Genes Dev., S, 2353-2361.
110. Waters, S.H., Saikh, K.U. and Stavnezer, J. (1989) A B-cell-specific nuclear protein that binds to DNA sites 5’ to immunoglobulin S-alpha tandem repeats is regulated during differentiation. Mol. Cell. Biol., 9, 5594-5601.
111. Wuerffel, R.A., Nathan, A.T. and Renter, A.L. (1990) Detection of an immunoglobulin switch region-specific DNA-binding protein in mitogen-stimulated mouse splenic B cells. Mol. Cell. Biol., 10, 1714-1718.
112. Renter, A.L. and Tredup, J. (1991) High expression of a 3'-5' exonuclease activity is specific to B lymphocytes. Mol. Cell. Biol., 11, 4398-4404.
113. Renter, A.L. and Watson, J.V. (1987) Cell cycle kinetics model of LPS-stimulated spleen cells correlates switch region rearrangements with S phase. J. Immunol. Methods, 97, 111-117.
114. Liu, Y.-J., Cairns, J.A., Holder, M.J., Abbot, S.D., Jansen, K.U., Bonnefoy, J.-Y., Gordon, J., and MacLennan, I.C.M. (1991) Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur. J. Immunol., 21, 1107-1114.
115. Liu, Y.-J., Johnson, G.D., Gordon, J. and MacLenna, I.C.M. (1992) Germinal centres in T-ce 11-dependent antibody responses. Immunol. Today, 13, 17-21.
116. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Walers, C.M., Pcnn, L.Z. and Hancock, D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
117. Askew, D.S., Ashmun, R.A., Simmons, B.C. and Cleveland, J.L. (1991)Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene, 6, 1915-1922.
118. Sabourin, L.A. and Hawley, R.G. (1990) Suppression of programmed death and G1 arrest in B-cell hybridemas by interleukin-6 is not accompanied by altered expression of immediate early response genes. J. Cell. Physiol., 145, 564-574.
119. Weinstein, P.D. and Cebra, J.J. (1991) The preference for switching to IgA expression by Peyer’s patch germinal center B cells is likely due to the intrinsic influence of their microenvironment. J. Immunol., 147, 4126-4135.
120. Huppi, K., Siwarski, D., Skurla, R., Klinman, D. and Mushinski, J.F. (1990)Pvt-1 transcripts are found in normal tissues and are altered by reciprocal (6; 15) translocations in mouse plasmacytomas. Proc. Natl. Acad Sci. USA, 87, 6964-6968.
121. Cory, S., Graham, M., Webb, E., Corcoran, L. and Adams, J.M. (1985)Variant (6; 15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBOJ., 4, 675-681.
122. Axelson, H., Panda, C.K., Silva, S., Sugiyama, H., Wiener, F., Klein, G. and Sumegi, J. (1991) A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda. Oncogene, 6, 2263-2270.
123. Mushinsld, J.F. (1988) c-myc oncogene activation and chromosomal translocation in BALB/c plasmacytomas. In Klein, G. (ed.), Cellular Oncogene Activation. Marcel Dekker, New York, pp. 181-222.
124. Ueber, M.R., Hesse, J.E., Mizuuchi, J. and Gellert, M. (1987) Developmental stage specificity of the lymphoid V(D)J recombination activity. Genes Dev., 1, 751-761.
125. Oettinger, M.A., Schatz, D.G., Gorka, C. and Baltimore, D. (1990) RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science, 248, 1517-1523.
126. Siminovitch, K.A., Moore, M.W., Durdik, J. and Selsing, E. (1987) The human kappa deleting element and the mouse recombining segment share DNA sequence homology. Nucleic Acids Res., 15, 2699-2705.
127. Feddersen, R.M. and Van Ness, B.G. (1990) Corrective recombination of mouse immunoglobulin kappa alleles in Abelson murine leukemia virus-transformed pre-B cells. Mol. Cell. Biol., 10, 569-576.
128. Osmond, D.G., Priddle, S. and Rico-Vargas, S. (1990) Proliferation of B cell precursors in bone marrow of pristane-condrtioned and malaria-infected mice: implications for B cell oncogenesis. In Potter, M. and Melchers, F. (eds), Current Topics in Microbiology and Immunology, Vol. 166: Mechanisms in B-Cell Neoplasia. Springer-Verlag, Heidelberg, pp. 149-157.
129. Pabst, R. (1988) The role of the spleen in lymphocyte migration. In Husband, AJ. (ed.). Migration and Homing of Lymphoid Cells. Vol. I, CRC Press, Boca Raton, FL, pp. 63-84.
130. DeFreitas, A.A. and Coutinho, A. (1981) Very rapid decay of mature B lymphocytes in the spleen. J. Exp. Med., 154, 994-999.
131. MacLennan, I.C.M., Oldfield, S., Liu, Y.-J. and Lane, PJ, L. (1988) Regulation of B cell populations. In Iversen, O.H. (ed.), Current Topics in Pathology: Kinetics of the Inflammatory Reaction Springer-Verlag, Heidelberg, pp. 37-57.
132. Fahrlander, P.D., Sumegi, J., Yang, J.-Q., Wiener, F., Marcu, K.B., and Klein, G. (1985) Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch regton-mediated chromosome rearrangements in a murine plasmacytoma. Proc. Natl. Acad. Sci. USA, 82, 3746-3750.
133. Ohno, S., Migita, S. and Murakami, S. (1991) c-myc gene in a murine plasmacytoma without visible chromosomal translocations moves to chromosome 12F1 with Pvt-1 and rearranges with IgH enhancer-S mu sequences. Ini. J. Cancer, 49, 102-108.
134. Shapiro, M. A. and Weigert, M. (1976) A complex translocation at the murine k light-chain locus. Mol. Cell. Biol., 7, 4130-4133.
135. VanNess, B.G., Shapiro, M., Kelley, D.E., Perry, R.P., Weigert, M., D’Eustachio, P. and Ruddle, F. (1983) Aberrant rearrangement of the kappa light-chain locus involving the heavy-chain locus and chromosome 15 in a mouse plasmacytoma. Nature, 301, 425-427.
136. Jack, H.-M., McDowell, M., Steinberg, C.M. and Wabl, M. (1988) Looping out and deletion mechanism for the imirunoglobulin heavy-chain class switch. Proc. Natl. Acad. Sci. USA, 85, 1581-1585.
137. Katz, A. and Kahana, C. (1989) Rearrangement between omithone decarboxylase and the switch region of the gamma 1 immunoglobulin gene in alpha-difluoromethylomithine resistant mouse myeloma cells. EMBOJ., 8, 1163-1167.
138. Calvo, C.-F., Giannini, S.L., Martinez, N. and Birshtein, B.K. (1991) DNA sequences 3' of the Ig H chain cluster rearrange in mouse B cell lines. J. Immunol., 146, 1353-1360.
139. Blackwood, E.M. and Eisenman, R.N. (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science, 251, 1211-1217.
140. Freytag, S.O. (1988) Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol. Cell. Biol., 8, 1614-1624.
141. Seth, A., Alvarez, E., Gupta, S. and Davis, R.J. (1991) A phosphorylation site located in the NH2-terminal domain of c-myc increases transactivation of gene expression. J. Biol. Chem., 266, 23521-23524.
142. Dang, C.V. (1991) c-myc oncoprotein function. Biochim. Biophys. Acta, 1072, 103-113.
143. Maheswaran, S., McCormack, J.E. and Sonenshein, G.E. (1991) Changes in phosporylalicm of myc oncogene and RB antioncogene protein products during growth arrest of the munne lymphoma WEHI 231 cell line. Oncogene, 6, 1965-1971.
144. Kato, G.J., Banett, J., Villa-Garcia, M. and Dang, C.V. (1990) An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol., 10, 5914-5920.
145. Freytag, S.O. and Geddes, TJ. (1992) Reciprocal regulation of adipogenesis by Myc and C/EBP alpha. Science, 256, 379-382.
146. Jackson, D.A. (1991) Structure-function relationships in eukaryotic nuclei. BioEssays, 13, 1-10.
147. Cook, P.R. (1991) The nucleoskeleton and the topology of replication. Cell, 66, 627-635.
148. Solomon, E., Borrow, J. and Goddard, A.D. (1991) Chromosome aberrations and cancer. Science, 254, 1153-1160.
149. Pardee, A.B. (1989) G1 events and regulation of cell proliferation. Science, 246, 603-608.
150. Axelson, H., Panda, C.K., Silva, S., Sugiyama, H., Wiener, F., Klein, G. and Sumegi, J. (1991) A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda. Oncogene, 6, 2263-2270.
151. Yang, J-Q., Bauer, S.R., Mushinski, J.F. and Marcu, K.B. (1985)Chromosome translocations clustered 5' of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation. EMBO J„ 4, 1441-1447.
152. Piccoli, S.P., Caimi, P.G. and Cole, M.D. (1984) A conserved sequence at c-myc oncogene chromosomal translocation breakpoints in plasmacytomas. Nature, 310, 327-330.
153. Bauer, S.R., Piechaczyk, M., Nordan, R.P., Owens, J., Nepveu, A., Marcu, K.B. and Mushinski J.F. (1989) Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas. Oncogene, 4, 615-623.
154. Cory, S., Gerondakis, S. and Adams, J.M. (1983) Interchromosomal recombination of the cellular oncogene c-myc with the immunoglobulin heavy chain locus in murine plasmacytomas is a reciprocal exchange. EMBO J., 2, 697-703.
155. Calame, K., Kim, S., Lalley, P., Hill, R., Davis, M. and Hood, L. (1982)Molecular cloning of translocations involving chromosome 15 and the immunoglobulin C-alpha gene from chromosome 12 in two murine plasmacytomas. Proc. Natl. Acad. Sci. USA, 79, 6994-6998.
156. Shen-Ong, G.L., Keath, E.J., Piccoli, S.P. and Cole, M.D. (1982) Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas. Cell, 31, 443-452.
157. Ohno, S., Migita, S. and Murakami, S. (1989) C-myc-S-mu rearrangement in a murine plasmacytoma without visible chromosomal translocations. Oncogene, 4, 1513-1517.